Janux Therapeutics (JANX) Asset Utilization Ratio (2021 - 2026)
Janux Therapeutics' (JANX) quarterly Asset Utilization Ratio came in at 0.01 in Q1 2026, up 53.08% year-on-year from 0.01 in Q1 2025, and up 37.1% on a QoQ basis from 0.01 in Q4 2025.
Janux Therapeutics (JANX) Asset Utilization Ratio (2021 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 6 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio rose 53.08% year-over-year to 0.01 in Q1 2026; TTM through Mar 2026 was 0.01, a 53.08% increase from a year earlier, with the FY2025 full-year figure at 0.01, down 33.99% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.01, up from 0.01 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for JANX reached as high as 0.03 in Q1 2023 and fell as low as 0.0 in Q2 2025.
- Historically, Asset Utilization Ratio has averaged 0.02 across 5 years, with a median of 0.02 in 2022.
- Across the five-year window, Asset Utilization Ratio soared 278.17% in 2022 and sank 98.08% in 2025, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.02 in 2022, then fell by 9.51% to 0.02 in 2023, then plunged by 42.78% to 0.01 in 2024, then fell by 18.13% to 0.01 in 2025, then jumped by 37.1% to 0.01 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.01 in Q1 2026, 0.01 in Q4 2025, and 0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Janux Therapeutics | 985.11 Mn | 985.11 Mn | - | 0.01 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.01 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.01 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.01 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.02 |
| Jun 30, 2023 | 0.02 |
| Mar 31, 2023 | 0.03 |
| Dec 31, 2022 | 0.02 |
| Sep 30, 2022 | 0.02 |
| Jun 30, 2022 | 0.02 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |